Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback-Reference-Cited by-同舟云学术

Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback

Published:2003-04 Issue:2 Volume:28 Page:109-116
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:

Author:

Monjanel-Mouterde S.,Ciccolini J.,Bagarry D.,Zonta-David M.,Duffaud F.,Favre R.,Durand A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2710.2003.00468.x/fullpdf

Reference24 articles.

1. Overview of platinum chemotherapy in head and neck cancer;Forastiere;Seminar in Oncology,1994

2. Meta-analysis of the role of platinum compounds in advanced ovarian carcinoma. The Advanced Ovarian Cancer Trialist Group;Williams;Seminar in Oncology,1992

3. Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up;Benedetti Panici;Interational Journal of Gynecological Cancer,1993

4. Plasma platinum levels: relationship to cis-platin dose and nephrotoxicity;Campbell;Cancer Treatment Report,1983

5. A systematic overview of chemotherapy effects in ovarian cancer;Hogberg;Acta Oncologica,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients;Pharmaceutics;2022-11-18

2. Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review;Expert Opinion on Drug Metabolism & Toxicology;2020-10-02

3. Towards Rational Cancer Therapeutics: Optimizing Dosing, Delivery, Scheduling, and Combinations;Clinical Pharmacology & Therapeutics;2020-08-02

4. Full-dose cisplatin chemotherapy combined with hemodialysis in a patient with impaired renal function and a mediastinal germ cell tumor;Anti-Cancer Drugs;2020-01-31

5. A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients;Scientific Reports;2017-06-02